§ Funding Round

ONL Therapeutics - $46.9M Series B

ONL Therapeutics raised $46.9M Series B venture round, led by Bios Partners.

AnnouncedSeries BEarly Stage Venture

Announced:Dec 24, 2020

About

This funding round does not have an about section yet.

Amount Raised

$46.9M

Pre-Money

N/A

Post-Money

N/A

Investor	Firm Type	Partner
Bios PartnersLEAD	Organization	—

This company has completed 7 funding rounds. Current round is highlighted.

Total Raised

$138.5M

Top Valuation

How much did ONL Therapeutics raise in this round?

ONL Therapeutics raised $46.9M in a Series B round.

When was the Series B round announced?

The round was announced on 12/24/20.

Who led the Series B round?

The round was led by Bios Partners.